Oral NRX 194204 Study in Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)

Clinical trial NCT00964132 · UNKNOWN

Trial details

NCT number: NCT00964132
Sponsor: NuRx Pharmaceuticals, Inc.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer

Start date: 2009-03-01
Primary completion: 2010-03-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.